Adherence to Long-Acting Inhaled Therapies among Patients with Chronic Obstructive Pulmonary Disease (COPD)

By Cecere Laura M.   Slatore Christopher G.   Uman Jane E.   Evans Laura E.   Udris Edmunds M.   Bryson Chris L.   Au David H.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 3, 2012-05 ,pp. : 251-258

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Corticosteroids With/Without Long-Acting -Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients

By Soriano J.B.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 1, 2003-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite

The Role of Tiotropium Bromide, a Long-Acting Anticholinergic Bronchodilator, in the Management of COPD

By Saberi Farzad   O'Donnell Denis E.  

Treatments in Respiratory Medicine, Vol. 4, Iss. 4, 2005-01 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

By Kerwin Edward M.   D'Urzo Anthony D.   Gelb Arthur F.   Lakkis Hassan   Gil Esther Garcia   Caracta Cynthia F.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 2, 2012-03 ,pp. : 90-101

Informa Healthcare

Access to resources Recommend Favorite

Clinical Safety of Long-Acting β 2 -Agonist and Inhaled Corticosteroid Combination Therapy in COPD

By Decramer Marc   Ferguson Gary  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 3, 2006-09 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite